New

Global ETF Survey 2026 Available: How 620 Professionals Select ETFs. Access the Report →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

Trackinsight Global ETF Survey 2026
VHT

Vanguard Health Care ETF

Passive ETFEquity

The VHT Exchange Traded Fund (ETF) is provided by Vanguard. It is built to track an index: MSCI US IMI Health Care 25/50 Index. The VHT ETF provides physical exposure, so by buying it you actually own parts of all the 408 underlying holdings. This share class generates a stream of income by distributing dividends.

Advertisement

Advertisement

$341.20
-$10 (-2.86%) yesterday
2:30 PM 11/05/26 Closed
1D price range
$341.07$354.83
52W price range
$264.97$354.83
YTD Perf.
+23.30%
YTD Flows
Annualized volatility
Fund AuM
€19.11B
Share class AuM
€19.11B
TTM Yield
Tracking Error
Tracking Difference
ISIN
US92204A5048
TER
0.09%
Inception date
1/26/2004
Issuer
Replication method
Dividend policy
API
PerformanceDec 31, 2025 - Nov 4, 2026
-10%-5%0%5%10%15%20%25%JANMARMAYJULSEPNOV
Flows
Join for free to unlock
Data as of 09/30/26
Healthcare
97.77%
Consumer Non-Cyclicals
1.55%
Unavailable
0.56%
Other
0.10%
Latest VHT news

FAQ about VHT

VHT is a passively managed ETF that invests in the US Health Care segment.
VHT tracks the MSCI US IMI Health Care 25/50 GTR Index - USD, through a full replication replication method.
VHT carries a total expense ratio (TER) of 0.09%.
VHT was introduced to the market on January 26, 2004.
Vanguard Health Care ETF, VHT, is provided by Vanguard. Learn more about Vanguard here.
VHT oversees €19.11B in assets as of November 4, 2026.
VHT follows a distributing dividend policy, meaning it pays out income to investors. As of November 4, 2026, its 12-month trailing yield was 1.31%.
As of September 30, 2026, VHT has significant geographic allocations in USA and Ireland.
As of September 30, 2026, VHT focuses largely on Healthcare and Consumer Non-Cyclicals.
As of September 30, 2026, VHT holds 408 positions in its portfolio, with 60.91% of assets concentrated in its top 15 holdings.
As of September 30, 2026, VHT top three holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..
The base currency of VHT is USD.
Data as of 09/30/26
Eli Lilly & Co.
12.93%
Johnson & Johnson
8.78%
AbbVie, Inc.
6.45%
Merck & Co., Inc.
5.01%
UnitedHealth Group, Inc.
4.65%
Thermo Fisher Scientific, Inc.
3.50%
Amgen, Inc.
3.18%
Gilead Sciences, Inc.
2.58%
Abbott Laboratories
2.40%
Pfizer Inc.
2.27%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring
Trackinsight Global ETF Survey 2026: ETFs' Next Act: From Access to Selection. Access the report

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight